Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer

Breast

Volumn 15, Issue 3, 2006, Pages 319-325

  Niehoff, Peter ^a   Ballardini, B ^b   Polgar C ^c   Major, T ^c   Hammer, J ^d   Richetti, A ^e   Kovacs G ^a,f  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b IRCCS   (Italy)

^c NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^d Krankenhaus der Barmherzigen Schwestern Linz   (Austria)

^e ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^f Department of Interdisciplinary Brachytherapy ^*  (Germany)

Author keywords

Brachytherapy; Breast cancer; MammoSite; Partial breast irradiation

Indexed keywords

ABSCESS; ADULT; AGED; ARTICLE; BALLOON; BRACHYTHERAPY; BREAST CANCER; CANCER PATIENT; CANCER RISK; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; ECHOGRAPHY; EUROPE; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HEMATOMA; HUMAN; MULTICENTER STUDY; PATIENT SELECTION; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLICATION; RADIATION APPLICATOR; RADIATION DOSE; RADIOGRAPHY; RISK ASSESSMENT; SEROMA; SKIN DISCOLORATION; SKIN INFLAMMATION; SURGICAL DRAINAGE; SURGICAL TECHNIQUE; TELANGIECTASIA; TREATMENT PLANNING;

EID: 33744906775     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2006.05.002     Document Type: Article

References (22)

1. WHO. Incidence, mortality and survival database (2002). http://www5.who.int/cancer/main.cfm
2. Fisher B., Bauer M., Margolese R., et al. Five year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312 (1985) 665-673
3. Hammer J., Mazeron J.J., and Van Limbergen E. Breast boost-why, how, when?. Strahlenther Onkol 175 10 (1999) 478-483
4. Fentiman I.S., Poole C., Tong D., et al. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer Apr 32 A (1996) 417-420
5. King T.A., Bolton J.S., Kuske R.R., et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for Tis,1,2 breast cancer. Am J Surg 180 4 (2000) 299-304
6. Lawenda B.D., Taghian A.G., Kachnic L.A., et al. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys 56 (2003) 671-680
7. Ott O.J., Pötter R., Hammer J., et al. Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy: preliminary results of the German-Austrian multicenter trial. Strahlenther Onkol 180 10 (2004) 642-649
8. Polgar C., Fodor J., Major T., et al. Radiotherapy confined to the tumour bed following breast conserving surgery: current status, controversies, and future prospects. Strahlenther Onkol 178 11 (2002) 597-606
9. Polgar C., Major T., Fodor J., et al. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study. Int J Radiat Oncol Biol Phys 60 (2004) 1173-1181
10. Arthur D.W., and Vicini F.A. MammoSite RTS: the reporting of initial experiences and how to interpret. Ann Surg Oncol 11 8 (2004) 723-724
11. Dickler A., Kirk M., Choo J., et al., Treatment volume and dose optimization of MammoSite breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 59 2 (2004) 469-474
12. Keisch M., Vicini F., Kuske R.R., et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 55 2 (2003) 289-293
13. Polgar C., Major T., Somogyi A., et al. CT-image-based conformal brachytherapy of breast cancer: the significance of semi-3-D and 3-D treatment planning. Strahlenther Onkol 176 (2000) 118-124
14. Harper J., Jenerette J.M., Vanek K.N., Aquero E.G., and Gillanders W.E. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience. Int J Radiat Oncol Biol Phys 61 1 (2005) 169-174
15. Shah N.M., Tenenholz T., Arthur D., et al. MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: factors that affect toxicity and cosmesis. Cancer 101 4 (2004) 727-734
16. Vicini FA, Beitsch P, Quiet C, et al. First analysis of patient demographics and technical reproducibility by the American Society of Breast Surgeons (ASBS) MammoSite breast brachytherapy registry trial in 801 patients treated with accelerated partial breast irradiation (APBI). In: Proceedings of the San Antonio breast cancer symposium, San Antonio, TX, 2004.
17. Richards G.M., Berson A.M., Rescigno J., et al. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early stage breast cancer. Ann Surg Oncol 11 8 (2004) 739-746
18. Van Limbergen E., Rijnders A., van der Schueren E., et al. Cosmetic evaluation of breast conserving treatment for mammary cancer. II. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results after tumor excision and radiotherapy. Radiother Oncol 16 (1989) 253-267
19. Van Limbergen E., van den Bogaert W., van der Schueren E., and Rijnders A. Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control. Radiother Oncol 8 (1987) 1-9
20. Van Limbergen E., Briot E., and Drijkoningen M. The source-skin distance measuring bridge: a method to avoid radiation teleangiectasia in the skin after interstitial therapy for breast cancer. Int J Radiat Oncol Biol Phys 18 5 (1990) 1239-1244
21. Turreson I. Individual variation and dose dependency in the progression rate of skin telangiectasia. Int J Radiat Oncol Biol Phys 19 (1990) 1569-1574
22. Dragun A.E., Aguero E.G., Harmon J.F., et al. Chest wall dose in MammoSite breast brachytherapy: radiobiologic estimations of late complication risk based on dose-volume considerations. Brachytherapy 4 (2005) 259-263